Patents by Inventor Peddaiahgari Seetharamulu

Peddaiahgari Seetharamulu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical formulations of taxanes
    Patent number: 6040330
    Abstract: A pharmaceutical formulation of a taxane antineoplastic agent, particularly paclitaxel or docetaxel or a pharmaceutically acceptable salt thereof, and N-methylpyrrolidin-2-one (NMP). The formulation may include other excipients and/or diluents, and is suitable for administration to patients with cancer.
    Type: Grant
    Filed: January 8, 1999
    Date of Patent: March 21, 2000
    Assignee: BioNumerik Pharmaceuticals, Inc.
    Inventors: Fredrick H. Hausheer, Dhanabalan Murali, Peddaiahgari Seetharamulu
  • Highly lipophilic camptothecin derivatives
    Patent number: 6028078
    Abstract: Novel compounds, formulations and methods of treating patients with cancer are provided for in this invention. The compounds are derivatives of camptothecin, and specifically relate to compounds having novel substitutions at the C-7 position of the camptothecin scaffold B-ring. The formula I compounds are highly lipophilic, lactone stable, do not require metabolic activation, and are potent antineoplastic compounds.
    Type: Grant
    Filed: October 26, 1998
    Date of Patent: February 22, 2000
    Assignee: BioNumerik Pharmaceuticals, Inc.
    Inventors: Frederick H. Hausheer, Pavankumar N. V. Petluru, Dasharatha Reddy, Dhanabalan Murali, Kochat Haridas, Peddaiahgari Seetharamulu, Shijie Yao
  • Highly lipophilic camptothecin derivatives
    Patent number: 5910491
    Abstract: Novel compounds, formulations and methods of treating patients with cancer are provided for in this invention. The compounds are derivatives of camptothecin, and specifically relate to compounds having novel substitutions at the C-7 position of the camptothecin scaffold B-ring. The formula I compounds are highly lipophilic, lactone stable, do not require metabolic activation, and are potent antineoplastic compounds.
    Type: Grant
    Filed: August 19, 1997
    Date of Patent: June 8, 1999
    Assignee: BioNumerik Pharmaceuticals, Inc.
    Inventors: Frederick H. Hausheer, Pavankumar N.V. Petluru, Dasharatha Reddy, Dhanabalan Murali, Kochat Haridas, Peddaiahgari Seetharamulu, Shijie Yao
  • Sterile aqueous parenteral formulations of cis-diammine dichloro platinum
    Patent number: 5789000
    Abstract: This invention describes a novel formulation containing both cis-diammine dichloro platinum and a water soluble disulfide, 2,2'-dithio-bis-ethane sulfonate in the same solution, wherein the presence of the disulfide and the parenteral administration of the formulation reduces the risk of cisplatin induced nephrotoxicity when treating human patients with cancer.
    Type: Grant
    Filed: November 14, 1994
    Date of Patent: August 4, 1998
    Assignee: Bionumerik Pharmaceuticals, Inc.
    Inventors: Frederick H. Hausheer, Kochat Haridas, Dhanabalan Murali, Dasharatha Gauravaram Reddy, Peddaiahgari Seetharamulu